GlassScriptPhysician profile
Yvonne M Liswell
NPI 1396878005
$780.18
in general payments reported to CMS, 2019-2025
8 companies · $405 in 2025
The $405 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $44.39 · 2023: $209 · 2024: $122 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $735.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $290.29 | 2023-2025 | Auvelity |
| Lilly USA, LLC | $149.73 | 2025 | Kisunla |
| Otsuka America Pharmaceutical, INC. | $133.37 | 2023-2025 | Rexulti, Nuedexta |
| Eisai INC. | $115.02 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.39 | 2021 | |
| Tms Neurohealth Centers INC. | $21.17 | 2025 | Tms Neurohealth Centers INC. |
| Abbvie INC. | $15.15 | 2024 | |
| Life Molecular Imaging LTD | $11.06 | 2023 | Neuraceq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yvonne Liswell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.